ArticleACS pharmacology & translational science2025
Toward Mitochondrial Targeting of Resistant Triple-Negative Breast Cancer Using Triphenylphosphonium-Conjugated Antimicrobial Peptides.
Eda Kapan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.